SCHEMBL7999213

SCHEMBL7999213

COCCCCCc1cc(C)ccc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.46
L3MBTL4 Q8NA19 1/20 0.45
L3MBTL3 Q96JM7 1/20 0.45
SLC13A5 Q86YT5 1/20 0.45
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 2/20 0.42
L3MBTL1 Q9Y468 8/20 0.41
MAPT P10636 6/20 0.41
HPGD P15428 6/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP2C9 P11712 3/20 0.41
CYP2C19 P33261 3/20 0.41
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991253 1.00 ACHE (0.46) ACHEL3MBTL4L3MBTL3SLC13A5ALDH1A1
SCHEMBL7990531 1.00 ACHE (0.46) ACHEL3MBTL4L3MBTL3SLC13A5ALDH1A1
SCHEMBL7989787 0.98 ACHE (0.47) ACHEL3MBTL4L3MBTL3SLC13A5ALDH1A1
SCHEMBL15186292 0.85 HTR2A (0.53) ACHESLC13A5L3MBTL1TDP1POLB
SCHEMBL12680827 0.84 SLC13A5 (0.44) ACHEL3MBTL4L3MBTL3SLC13A5ALDH1A1
SCHEMBL13845938 0.82 ADRA1A (0.39) ADRA1ATAAR1
SCHEMBL13845934 0.82 ADRA1A (0.39) ADRA1ATAAR1
SCHEMBL13845991 0.82 ADRA1A (0.39) ADRA1ATAAR1
SCHEMBL2934176 0.80 KDM4E (0.48) ALDH1A1L3MBTL1MAPTSMN1; SMN2TDP1
SCHEMBL8053664 0.78 SLC13A5 (0.47) ACHEL3MBTL4L3MBTL3SLC13A5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117594-A1 FLUORINATED MACROCYCLIC COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-09-24 WO disclosed
WO-2009079353-A1 TRIAZOLE-CONTAINING MACROCYCLIC HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-06-25 WO disclosed